Tunib 12.5 Capsule
Marketer
Panacea Biotec Pharma Ltd
Salt Composition
Sunitinib (12.5mg)
Overview Tunib 12.5 Capsule
Axitinib 12.5mg capsules are prescribed for kidney cancer and gastrointestinal stromal tumors. Their mechanism involves inhibiting specific enzymes crucial for cancer cell proliferation, resulting in tumor shrinkage and slowed growth. Axitinib 12.5mg capsules may be administered with or without food, but consistent daily timing optimizes efficacy. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strictly adhere to your doctor's instructions; incorrect usage or overdosage can lead to severe adverse reactions. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include fatigue, loose stools, queasiness, vomiting, altered taste perception, and reduced appetite. Regular blood pressure and thyroid function monitoring may be recommended. Hypoglycemia, potentially severe enough to cause fainting, is possible; diabetics should monitor blood glucose levels closely and discuss potential antidiabetic medication adjustments with their doctor. Prior to commencing treatment, disclose any pre-existing heart, liver, kidney conditions, or bleeding disorders. Inform your healthcare provider of all concurrent medications, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception for both partners is essential throughout treatment.
Uses of Tunib 12.5 Capsule
Kidney and gastrointestinal stromal tumor therapies
Major Benefits of Tunib 12.5 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Tunib 12.5 Capsule. This medication can be administered with or without food, although consistent timing is recommended.
Common Side effects of Tunib 12.5 Capsule:
- Hand-foot syndrome
- Bleeding disorder
- Low blood platelets
- Decreased appetite
- Nausea
- Vomiting
- Weakness
- Abdominal pain
- Indigestion
- High blood pressure
- Diarrhea
- Stomatitis (Inflammation of the mouth)
- Taste change
How to use Tunib 12.5 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Tunib 12.5 Capsules can be ingested with or without food, however, consistent timing is recommended.
How Tunib 12.5 Capsule works:
Cellab 12.5mg capsules are an oncology drug that inhibits the activity of specific tyrosine kinase receptors on cancer cells. This action prevents cancerous cell multiplication and simultaneously reduces tumor angiogenesis, thus limiting cancer progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Tunib 12.5 Capsule may pose unknown safety risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Tunib 12.5 Capsule during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Tunib 12.5 Capsule while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Tunib 12.5 Capsule, which can induce dizziness. Refrain from driving or operating machinery should dizziness occur during treatment.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Tunib 12.5 Capsule is considered safe. No dosage modification is needed for this medication.
LiverSAFE IF PRESCRIBED
Patients with hepatic impairment can safely use Tunib 12.5 Capsule without requiring any modification to the prescribed dosage.
What if you forget to take Tunib 12.5 Capsule :
Omit any missed Tunib 12.5 Capsule dose and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Tunib 12.5 Capsule
| Label | Value |
|---|---|
| Chemical Type | Indole and Pyrrole Derivatives |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |



